Abstract

Pharmacoeconomic Assessment of Sucroferric Oxyhydroxide Vs Sevelamer Carbonate In Patients With Chronic Kidney Disease In Belgium and The Netherlands

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call